These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 23300771)
1. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43. Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771 [TBL] [Abstract][Full Text] [Related]
2. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43). Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684 [TBL] [Abstract][Full Text] [Related]
3. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state. Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43). Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008 [TBL] [Abstract][Full Text] [Related]
5. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080 [TBL] [Abstract][Full Text] [Related]
6. Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site. Furukawa Y; Kaneko K; Nukina N Biochim Biophys Acta; 2011 Dec; 1812(12):1577-83. PubMed ID: 21946215 [TBL] [Abstract][Full Text] [Related]
7. The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates. Wang YT; Kuo PH; Chiang CH; Liang JR; Chen YR; Wang S; Shen JC; Yuan HS J Biol Chem; 2013 Mar; 288(13):9049-57. PubMed ID: 23372158 [TBL] [Abstract][Full Text] [Related]
8. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357 [TBL] [Abstract][Full Text] [Related]
9. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions. Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288 [TBL] [Abstract][Full Text] [Related]
10. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS. Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167 [TBL] [Abstract][Full Text] [Related]
11. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125 [TBL] [Abstract][Full Text] [Related]
12. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Kuo PH; Doudeva LG; Wang YT; Shen CK; Yuan HS Nucleic Acids Res; 2009 Apr; 37(6):1799-808. PubMed ID: 19174564 [TBL] [Abstract][Full Text] [Related]
13. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Zhang YJ; Caulfield T; Xu YF; Gendron TF; Hubbard J; Stetler C; Sasaguri H; Whitelaw EC; Cai S; Lee WC; Petrucelli L Hum Mol Genet; 2013 Aug; 22(15):3112-22. PubMed ID: 23575225 [TBL] [Abstract][Full Text] [Related]
14. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals. Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239 [TBL] [Abstract][Full Text] [Related]
15. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185 [TBL] [Abstract][Full Text] [Related]
16. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing. Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909 [TBL] [Abstract][Full Text] [Related]
17. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates. Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551 [TBL] [Abstract][Full Text] [Related]
18. Structural Rearrangement upon Fragmentation of the Stability Core of the ALS-Linked Protein TDP-43. Morgan BR; Zitzewitz JA; Massi F Biophys J; 2017 Aug; 113(3):540-549. PubMed ID: 28793209 [TBL] [Abstract][Full Text] [Related]
19. RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43. Takagi S; Iguchi Y; Katsuno M; Ishigaki S; Ikenaka K; Fujioka Y; Honda D; Niwa J; Tanaka F; Watanabe H; Adachi H; Sobue G PLoS One; 2013; 8(6):e66966. PubMed ID: 23840565 [TBL] [Abstract][Full Text] [Related]
20. Characterization of TDP-43 RRM2 Partially Folded States and Their Significance to ALS Pathogenesis. Tavella D; Zitzewitz JA; Massi F Biophys J; 2018 Nov; 115(9):1673-1680. PubMed ID: 30309612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]